Transaction · 0001669639-26-000004

Sanzone Virginia Ruth

Sanzone Virginia Ruth, VP, GC, reported an open-market or private sale at ICU MEDICAL INC/DE involving 1238.000000 shares for an estimated $208522.78. Reported holdings after the transaction were 16020.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SVP, GC
ICUIICU MEDICAL INC/DE
Filing timeSep 03
Trade dateSep 03, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$166.29
Pre-filing
1mo ago1w ago1d ago +2.1%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

ICUI price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ICUI since 2026-09-03Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001669639-26-000004
Common Stock
Transaction date
Sep 03, 2026
Filed Sep 03, 2026, 10:29 PM · 0d delay
Shares
1.23k sh
$16.8k per share
Estimated value
-$20.8M
Computed from shares × price
Holdings after
16.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

VP, General Counsel

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026.

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.20 to $168.145, inclusive. The reporting person undertakes to p…

  3. F3

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.21 to $169.15, inclusive. The reporting person undertakes to pr…

  4. F4

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.5 to $169.665, inclusive. The reporting person undertakes to pr…

  5. F5

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.775 to $171.69, inclusive. The reporting person undertakes to p…

Original filing · 0001669639-26-000004
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ICUI